1. Home
2. NICE Guidance
3. Conditions and diseases
4. Kidney conditions
5. Chronic kidney disease

Targeted-release budesonide for treating primary IgA nephropathy with a urine protein-to-creatinine ratio of 0.8 g/g or more (review of TA937) [ID6485]